{"id":"W2919740967","doi":"10.1177/1759720x19831151","title":"Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Musculoskeletal Disease","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland; McMaster University; Université du Québec à Rimouski; University of Toronto; Centre Hospitalier de l’Université de Montréal; Wilfrid Laurier University; Université Laval","funders":"Novartis Pharma; UCB; UCB Pharma; Pfizer; Eli Lilly and Company","keywords":"Medicine; Certolizumab pegol; Rheumatoid arthritis; Observational study; Adverse effect; Internal medicine; Physical therapy; Incidence (geometry); Bristol-Myers; Minimal clinically important difference; Randomized controlled trial; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004774034,0.0002173277,0.0004453549,0.0002119053,0.00006371844,0.00002219968,0.000179011,0.00005349088,0.00006911007],"category_scores_gemma":[0.0008704119,0.0001723385,0.00006738808,0.0004431115,0.0002023098,0.000460178,0.0000559609,0.0003360176,0.000009999892],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002279702,"about_ca_system_score_gemma":0.0004929255,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.05554099,"about_ca_topic_score_gemma":0.1317963,"domain_scores_codex":[0.9972431,0.0007362268,0.0005704129,0.0004483206,0.0005406077,0.0004613295],"domain_scores_gemma":[0.9978333,0.001216072,0.000125458,0.0004181891,0.0001302211,0.000276769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007778388,0.0008063479,0.9179233,0.00007699973,0.00005070432,0.00008861083,0.001186837,0.00007823261,0.00001445773,0.0006006106,0.000001049747,0.07139449],"study_design_scores_gemma":[0.01823625,0.0004632847,0.9753594,0.0009725621,0.000004694729,0.000003179717,0.001835822,0.0001933878,0.000003161579,0.001727979,0.001029463,0.0001708145],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9822252,0.01347103,0.000002975622,0.001202074,0.00009378188,0.002394116,0.000302139,0.00001028898,0.0002984291],"genre_scores_gemma":[0.9705834,0.02897804,0.00003870594,0.00007519916,0.00001149502,0.0001219687,0.0001614012,0.00002529543,0.000004526437],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07625532,"threshold_uncertainty_score":0.9507483,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01027250520756002,"score_gpt":0.3003478798743314,"score_spread":0.2900753746667714,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}